AbbVie Inc.
ABBV · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $410 | $329 | $370 | $314 |
| - Cash | $6 | $6 | $5 | $6 |
| + Debt | $69 | $70 | $70 | $68 |
| Enterprise Value | $473 | $393 | $435 | $377 |
| Revenue | $16 | $15 | $13 | $15 |
| % Growth | 2.3% | 15.6% | -11.6% | – |
| Gross Profit | $12 | $13 | $9 | $11 |
| % Margin | 78.5% | 84.4% | 70% | 70.9% |
| EBITDA | $3 | $4 | $4 | $1 |
| % Margin | 21.8% | 28.2% | 33% | 3.5% |
| Net Income | $0 | $1 | $1 | -$0 |
| % Margin | 1.2% | 6.1% | 9.6% | -0.1% |
| EPS Diluted | 0.1 | 0.53 | 0.72 | -0.018 |
| % Growth | -81.1% | -26.4% | 4,077.9% | – |
| Operating Cash Flow | $7 | $5 | $2 | $7 |
| Capital Expenditures | $1 | -$0 | -$0 | -$0 |
| Free Cash Flow | $8 | $5 | $1 | $7 |